Market Closed -
Hong Kong S.E.
04:08:22 2024-05-10 am EDT
|
5-day change
|
1st Jan Change
|
0.106
HKD
|
+6.00%
|
|
+6.00%
|
+2.91%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
394.2
|
453
|
495.8
|
449
|
178.3
|
250.6
|
Enterprise Value (EV)
1 |
1,302
|
1,436
|
1,598
|
1,664
|
1,420
|
1,421
|
P/E ratio
|
-1.97
x
|
-0.63
x
|
-1.32
x
|
-0.89
x
|
-0.14
x
|
-0.95
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.07
x
|
1.4
x
|
2.55
x
|
1.96
x
|
0.48
x
|
2.48
x
|
EV / Revenue
|
3.54
x
|
4.45
x
|
8.22
x
|
7.26
x
|
3.84
x
|
14.1
x
|
EV / EBITDA
|
-90.5
x
|
-43.3
x
|
-13.4
x
|
-6.6
x
|
-10
x
|
-24.4
x
|
EV / FCF
|
-8.78
x
|
-12.8
x
|
35.5
x
|
6.77
x
|
31.7
x
|
-4.15
x
|
FCF Yield
|
-11.4%
|
-7.82%
|
2.82%
|
14.8%
|
3.16%
|
-24.1%
|
Price to Book
|
0.25
x
|
0.57
x
|
1.32
x
|
15.2
x
|
-0.2
x
|
-0.26
x
|
Nbr of stocks (in thousands)
|
55,521
|
66,621
|
66,996
|
80,185
|
133,028
|
527,548
|
Reference price
2 |
7.100
|
6.800
|
7.400
|
5.600
|
1.340
|
0.4750
|
Announcement Date
|
10/30/18
|
10/30/19
|
11/1/20
|
11/16/21
|
10/31/22
|
12/22/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
367.6
|
323
|
194.3
|
229
|
369.6
|
100.8
|
EBITDA
1 |
-14.39
|
-33.14
|
-119.5
|
-252
|
-141.8
|
-58.17
|
EBIT
1 |
-153.2
|
-153.5
|
-192.9
|
-324.5
|
-215.2
|
-114.6
|
Operating Margin
|
-41.67%
|
-47.51%
|
-99.25%
|
-141.68%
|
-58.23%
|
-113.61%
|
Earnings before Tax (EBT)
1 |
-225.9
|
-698.8
|
-384.6
|
-458.7
|
-1,074
|
-186.5
|
Net income
1 |
-199.3
|
-667.4
|
-373.2
|
-450.4
|
-1,064
|
-155.9
|
Net margin
|
-54.22%
|
-206.59%
|
-192.02%
|
-196.64%
|
-287.91%
|
-154.57%
|
EPS
2 |
-3.596
|
-10.84
|
-5.588
|
-6.270
|
-9.812
|
-0.4984
|
Free Cash Flow
1 |
-148.2
|
-112.3
|
45.06
|
245.8
|
44.83
|
-342.2
|
FCF margin
|
-40.31%
|
-34.75%
|
23.19%
|
107.31%
|
12.13%
|
-339.35%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/30/18
|
10/30/19
|
11/1/20
|
11/16/21
|
10/31/22
|
12/22/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
907
|
983
|
1,102
|
1,215
|
1,241
|
1,170
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-63.07
x
|
-29.67
x
|
-9.222
x
|
-4.82
x
|
-8.751
x
|
-20.12
x
|
Free Cash Flow
1 |
-148
|
-112
|
45.1
|
246
|
44.8
|
-342
|
ROE (net income / shareholders' equity)
|
-12.3%
|
-54.9%
|
-59.4%
|
-203%
|
292%
|
21%
|
ROA (Net income/ Total Assets)
|
-3.03%
|
-3.52%
|
-5.65%
|
-10.1%
|
-8.13%
|
-7.52%
|
Assets
1 |
6,586
|
18,936
|
6,599
|
4,444
|
13,092
|
2,073
|
Book Value Per Share
2 |
28.50
|
12.00
|
5.600
|
0.3700
|
-6.560
|
-1.810
|
Cash Flow per Share
2 |
1.120
|
0.1100
|
0.1200
|
0.5800
|
0.1000
|
0.0100
|
Capex
1 |
25.1
|
18.2
|
19.7
|
18.8
|
43.2
|
8.01
|
Capex / Sales
|
6.82%
|
5.65%
|
10.12%
|
8.19%
|
11.69%
|
7.94%
|
Announcement Date
|
10/30/18
|
10/30/19
|
11/1/20
|
11/16/21
|
10/31/22
|
12/22/23
|
|
1st Jan change
|
Capi.
|
---|
| +2.91% | 12.8M | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 42.95B | | +17.44% | 39.2B | | +6.62% | 33.01B | | +13.00% | 20.33B | | +15.64% | 17.29B | | +22.55% | 15.72B | | +7.34% | 14.72B |
Other Commodity Chemicals
|